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Members of the genus Bifidobacterium are abundant in the stool of most human infants during
the initial exclusively milk-fed period of life, especially at an age of 2–3 months (Harmsen et al.,
2000; Favier et al., 2002; Mariat et al., 2009; Coppa et al., 2011; Turroni et al., 2012; Yatsunenko
et al., 2012; Tannock et al., 2013; Barrett et al., 2015). Bifidobacteria dominate the stool microbiota
regardless of whether the infants are fed human milk or formula based on ruminant milk (cow
or goat). However, bifidobacteria have about 20% higher relative abundances in human milk-fed
compared to formula-fed babies (Tannock et al., 2013). The greater abundance of bifidobacteria in
human-milk-fed infants can, at least in part, be explained by the fact that bifidobacterial species
that are enriched in the infant bowel can utilize Human Milk Oligosaccharides (HMO) or their
components as growth substrates (Sela et al., 2008; LoCascio et al., 2010; Garrido et al., 2013). It
could be anticipated, therefore, that bifidobacteria would be detectable in the stool microbiota of
every child nourished at the breast because of the supply of appropriate growth substrates. This
expectation is not borne out completely because a proportion of infants have very low abundance
or undetectable bifidobacteria as members of the fecal microbiota regardless of breast milk or
formula feeding (Young et al., 2004; Gore et al., 2008; Tannock et al., 2013). Antibiotics had not
been administered to these infants. How then can the absence of bifidobacteria be explained?
A GROWTH SUBSTRATE DEFICIT?
The “bifidobacteria-negative” babies have been detected in both human milk and formula-fed
infants. Therefore, a bacterial growth substrate effect seems unlikely. While human milk is rich
in HMO and ruminant milk lacks these complex molecules (although simpler forms such as
sialylated-lactose are present in very small amounts), bifidobacteria are still the most abundant
taxon in the feces of infants fed formula un-supplemented with galacto- or fructo-oligosaccharides
(Tannock et al., 2013). In this case, lactose and/or glycoproteins and glycolipids are probable growth
substrates for bifidobacteria (Turroni et al., 2010; Bottacini et al., 2014; O’Callaghan et al., 2015) in
the bowel of exclusively milk fed infants. There is, however, a need to support genomic analysis
of bifidobacteria with culture-based investigations of bifidobacterial nutrition based on substrates
present in the bowel of exclusively milk-fed babies (other than HMO).
LACK OF SENSITIVITY OF BIFIDOBACTERIAL DETECTION
METHODS?
An obvious reason for bifidobacteria-negative feces is that the detection methods lack sufficient
sensitivity. Culture-based methods usually have a lower detection limit of 1 × 103 per gram,
fluorescent in situ hybridization (FISH) 1 × 106 − 107 per gram (manual or digital counts
respectively) or ∼4 × 104 by flow cytometry, and denaturing gradient gel electrophoresis of PCR
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amplicons ∼1 × 105 – 106 cells (Welling et al., 1997; Jansen
et al., 1999; Zoetendal et al., 2001, 2002) or 1× 104 using internal
transcribed spacer targets (Milani et al., 2014). High throughput
DNA sequencing methods, such as Illumina, generate tens of
thousands of 16S rRNA gene sequences per DNA sample, but
there may be several hundred OTU per sample. Thus, taxa
present in very low abundance could be missed. However,
reference to rarefaction curves (alpha diversity) during sequence
analysis will show whether coverage of the microbiota is near
complete or not. Therefore, while lack of sufficient sensitivity
of detection methods remains a possibility, it probably does not
provide the total explanation.
BIFIDOBACTERIAL POPULATIONS RISE
AND FALL FROM DAY TO DAY?
Most fecal microbiota studies examine a single fecal sample
from each participating individual. Comprehensive temporal
studies of the fecal microbiota to determine day-to-day variations
in composition have not been reported. It is possible that
bifidobacteria are present in the feces of all children during early
life but that, on some days, the bifidobacterial population falls
to undetectable levels. Populations of bifidobacteria in the feces
of some adults without diseases are dynamic in terms of strain
composition, so there is some support for a concept of temporal
instability in the bifidobacterial population of the microbiota
(McCartney et al., 1996). Figure 1A shows data from feces
collected at intervals from infants during the first 12 weeks of life.
In the example, fluctuations in the abundances of bifidobacteria
were seen, varying from very low abundance to absence, in
feces of individual children. Strikingly, bifidobacteria were not
detected in any of the fecal samples of one child. Therefore,
bifidobacteria-free infants do seem to be a real phenomenon.
THE WINDOW OF INFECTIVITY
(OPPORTUNITY/COLONIZATION) WAS
MISSED?
A window of opportunity is a short time period during which an
otherwise unattainable opportunity exists. After the window of
opportunity closes, the opportunity ceases to exist. Caufield was
the first to describe the “window of infectivity” in the acquisition
of commensal bacteria. His example was Streptococcus mutans in
the oral cavity of children (Caufield et al., 1993; Li and Caufield,
1995). This bacterial species is associated with dental plaque, thus
the window of infectivity coincided with the eruption of the first
molars. Prior to this, a habitat for S. mutans is not available
in the oral cavity of children for this species. The Caufield
hypothesis reminds us that many factors have to coincide to
favor the establishment of a commensal in a body site. Cesarean-
delivered babies have lower prevalences of bifidobacteria in their
feces in early life (Figure 1B). By analogy to Caufield’s studies,
this probably relates to a lack of favorable opportunities for
bifidobacteria to colonize the bowel relative to the vaginal birth
process. Notably, we found that 36% of cesarean-derived babies
lacked bifidobacteria, whereas 18% of vaginally delivered infants
were bifidobacteria-free at 2 months of age (Tannock et al., 2013).
OTHER TAXA REPLACE BIFIDOBACTERIA
IN SOME BABIES?
If bifidobacteria have not colonized the bowel of certain
infants, they are likely to be replaced by other taxa, which
may have the requisite metabolic properties to fill the vacant
ecological niche. In a study of the fecal microbiotas of Australian
babies that were breast milk- or formula-fed, we compared
the relative abundances of bacterial taxa in infants that had
very low (<10%) or higher (>10%) bifidobacterial content
(Tannock et al., 2013). Analysis of the compositions of these
microbiotas showed that when Bifidobacteriaceae abundance was
low, Lachnospiraceae abundances tended to be greater in babies
in all dietary groups (Figures 1C–E). There was also a tendency
for Erysipelotrichaceae abundances to be greater in formula-fed
babies with low bifidobacterial abundances, being much more
evident in the case of goat milk-fed infants. These observations
suggest that, yes, other taxa might replace bifidobacteria in the
fecal microbiota of some children.
WHAT ARE THE CONSEQUENCES OF
LACKING BIFIDOBACTERIA IN THE
BOWEL?
The absence of bifidobacteria in the bowel may be detrimental
for infant development. The curious phenomenon whereby
mother’s milk contains substances not used in the nutrition of
the offspring, but which fertilize bifidobacterial growth, is unique
to humans. There must be a good reason for this. Enriching
bifidobacterial populations in the bowel tends to minimize the
abundance of other bacterial species, so a competitive exclusion
function could be ascribed to HMO. Additionally, HMO may
act as “decoys” in the bowel by binding to pathogens (bacteria
and viruses) and their toxins and thus limiting contact with
mucosal surfaces (Kunz et al., 2000). The large diversity of HMO
structures that is known to occur in human milk suggests a large
diversity of decoy functions (Pacheco et al., 2015). Irrespective
of where in the World babies live, their gut microbiomes are
enriched in genes involved in the de novo biosynthesis of folate
(Yatsunenko et al., 2012). In contrast, the microbiome of adults
favors synthesis of another B vitamin, cobalamin. Folate synthesis
is an attribute of bifidobacteria and folate can be absorbed
from the large bowel, so enrichment of bifidobacteria in the
infant bowel may provide an important contribution to infant
nutrition (Aufreiter et al., 2009; D’Aimmo et al., 2012; Lakoff
et al., 2014). Folate functions as a coenzyme or co-substrate
in single-carbon transfers in the synthesis of nucleic acids
and metabolism of amino acids. One of the most important
folate-dependent reactions is the conversion of homocysteine
to methionine in the synthesis of S-adenosyl-methionine, an
important methyl donor. Another folate-dependent reaction, the
methylation of deoxyuridylate to thymidylate in the formation
of DNA, is required for proper cell division (Crider et al., 2012).
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FIGURE 1 | (A) Examples of babies without bifidobacteria, or very low abundances of bifidobacteria, in feces during the first 12 weeks of life. Bifidobacteria were
undetectable by DNA sequencing of 16S rRNA gene amplicons at 6 and 12 weeks in the feces of AF067; 6, 8, 10, and 12 weeks in AF70; 8 and 10 weeks in AF075;
and 6 and 12 weeks in AF090. (B) Comparison of bifidobacerial abundances in the feces of infants delivered vaginally or by cesarean. Note that in both groups,
bifidobacteria were not detected in some infants. (C) Comparison of abundances of bacterial families in microbiotas of breast milk-fed infants in relation to
abundances of bifidobacteria. (D) Comparison of abundances of bacterial families in microbiotas of cow milk formula-fed infants in relation to abundances of
bifidobacteria. (E) Comparison of abundances of bacterial families in microbiotas of goat milk formula-fed infants in relation to abundances of bifidobacteria. Note that
Lachnospiraceae have increased abundances when bifidobacteria have low relative abundance. Figures after Tannock et al. (2013), reproduced with permission.
Neonatal nutrition could, indeed, be the very important reason
for the HMO-bifidobacteria-infant paradigm. The foundation of
brain structure and function is set early in life through genetic,
biological and psychosocial influences. The rate of neonatal brain
growth exceeds that of any other organ or body tissue (Wang,
2012). The infant is born with neurons already formed but the
synaptic connections between these cells are mostly established
and elaborated after birth causing a large nutritional demand for
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biosynthesis of gangliosides (Svennerholm et al., 1989). Nutrition
of the infant in early life affects brain developmental processes
including cognition (Uauy and Peirano, 1999; Uauy et al.,
2001). While long-chain fatty acids (such as docosahexaenoic
acid) have been the focus of much of the research in this
field, tantalizing research evidence now indicates that sialic acid
(N-acetyl-neuraminic acid), a 9-carbon carbohydrate, is also an
essential nutrient for optimal brain development and cognition
(Gibson, 1999; Meldrum et al., 2012; Wang, 2012). Strikingly,
cortical tissue from human brain contains up to 4 times more
sialic acid than that of other mammals tested (Wang et al.,
1998). Moreover, the sialic acid concentration in the brain of
breast milk-fed babies is higher than in that of formula-fed
infants (Wang et al., 2003). These facts correlate with the unique
biochemistry of human milk and the unique bacteriology of the
infant bowel. Intriguingly, Ruhaak et al. (2014) have reported the
detection of sialylated oligosaccharides (3′ sialyl-lactose, 6′ sialyl-
lactose, 3′ sialyl-lactosamine, 6′ sialyl-lactosamine) that might
result from the hydrolysis of HMO, in the blood of human
infants. Thus, bifidobacterial biochemistry in the bowel may
have extra-intestinal, nutritional influences important in brain
development. However, perhaps the taxa that are abundant in the
bowel of infants in the absence of bifidobacteria can carry out
these same functions? This interesting possibility remains to be
investigated.
BABIES WITHOUT BIFIDOBACTERIA ARE
IMPORTANT SOURCES OF KNOWLEDGE?
Rene Dubos explored in a number of books the interplay between
environmental forces and the physical, mental, and spiritual
development of humankind. His article published in the journal
Pediatrics entitled “Biological Freudianism: lasting effects of early
environmental influences” encapsulated this theme (Dubos et al.,
1966). Drawing on the results of experiments conducted with
specific-pathogen-free mice, the authors concluded that “From
all points of view, the child is truly the father of the man, and
for this reason we need to develop an experimental science that
might be called biological Freudianism. Socially and individually
the response of human beings to the conditions of the present
is always conditioned by the biological remembrance of things
past.”
Biological Freudianism is clearly of relevance to the concept
that the first 1000 days, between conception and the child’s
second birthday, offer a unique window of opportunity to shape
healthier and more prosperous futures. Nutrition during this
1000 day window can have a profound impact on a child’s
ability to grow, and learn. The influences of the microbiota on
the development of the child during early life are potentially
very important, and much longitudinal research is required
to clarify whether there are continuing, medically important
impacts of the microbiota, inlcuding the bifidobacteria, that last
throughout the lifetime of humans. Comparisons of the cognitive
development and general health status of children that had been
bifidobacteria-free, and children that were ex-bifidobacteria-free
then intentionally exposed to bifidobacteria, in a longitudinal
study extending perhaps 10 or 20 years, would tell us
whether these bacteria optimize short and/or long term human
development and health.
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